Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Congo Red Free Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB known ✓ | P10828 | 2/20 | 0.74 |
| ▸ | APP | P05067 | 2/20 | 1.00 |
| ▸ | GLB1 | P16278 | 1/20 | 1.00 |
| ▸ | CHAT | P28329 | 1/20 | 1.00 |
| ▸ | ENPP2 | Q13822 | 1/20 | 1.00 |
| ▸ | PHLPP2 | Q6ZVD8 | 1/20 | 1.00 |
| ▸ | CTRC | Q99895 | 1/20 | 1.00 |
| ▸ | SLC7A11 | Q9UPY5 | 2/20 | 0.81 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.74 |
| ▸ | HPGD | P15428 | 2/20 | 0.74 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.74 |
| ▸ | RECQL | P46063 | 2/20 | 0.74 |
| ▸ | MEN1 | O00255 | 1/20 | 0.74 |
| ▸ | MAPT | P10636 | 1/20 | 0.74 |
| ▸ | SNCA | P37840 | 1/20 | 0.74 |
| ▸ | BLM | P54132 | 1/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.74 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.74 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.71 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Congo Red Free Acid SCHEMBL25635 | 1.00 | APP (1.00) | APPGLB1CHATENPP2PHLPP2 | |
| Congo Red Free Acid SCHEMBL202229 | 1.00 | APP (1.00) | APPGLB1CHATENPP2PHLPP2 | |
| Congo Red Free Acid SCHEMBL29366109 | 1.00 | APP (1.00) | APPGLB1CHATENPP2PHLPP2 | |
| Congo Red Free Acid SCHEMBL326084 | 0.97 | APP (0.95) | APPGLB1CHATENPP2PHLPP2 | |
| Congo Red Free Acid SCHEMBL326085 | 0.97 | APP (0.95) | APPGLB1CHATENPP2PHLPP2 | |
| SCHEMBL14988500 | 0.94 | APP (0.88) | APPGLB1CHATENPP2PHLPP2 | |
| SCHEMBL14988686 | 0.92 | APP (0.85) | APPGLB1CHATENPP2PHLPP2 | |
| SCHEMBL20553442 | 0.91 | APP (0.84) | APPGLB1CHATENPP2PHLPP2 | |
| SCHEMBL14988379 | 0.90 | APP (0.80) | APPGLB1CHATENPP2PHLPP2 | |
| SCHEMBL14988623 | 0.90 | APP (0.81) | APPGLB1CHATENPP2PHLPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 156 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250269070-A1 | Fluorescent Marker | UCL BUSINESS PLC (GB) | 2025-08-28 | — | — | US | claimed |
| EP-4083621-B1 | PH SENSITIVE COLOR INDICATOR FOR SANITIZING APPLICATIONS | ECOLAB USA INC (US) | 2025-05-14 | — | — | EP | claimed |
| EP-3650048-B1 | SOLID ORAL COMPOSITION CONTAINING DYES FOR USE IN ENDOSCOPIC DIAGNOSIS | COSMO TECHNOLOGIES LTD (IE) | 2025-03-05 | — | — | EP | claimed |
| EP-3847459-B1 | SYSTEMS, SENSORS AND METHODS FOR DETERMINING A CONCENTRATION OF AN ANALYTE | AUSMED GLOBAL LTD (CN) | 2025-02-26 | — | — | EP | claimed |
| EP-4444275-A1 | SYNERGISTIC TRANSPORT OF LIPOPHILIC AND HYDROPHILIC ACTIVE SUBSTANCES IN NANOPARTICLES | Karlsruher Institut für Technologie (DE) | 2024-10-16 | — | — | EP | claimed |
| EP-3745127-B1 | METHODS AND COMPOSITIONS FOR DETECTING MISFOLDED PROTEINS | UNIV YALE (US) | 2024-08-28 | — | — | EP | claimed |
| EP-3892228-B1 | MEDICAL INSTRUMENT OR PART OF A MEDICAL INSTRUMENT | AESCULAP AG (DE) | 2024-05-08 | — | — | EP | claimed |
| EP-4007909-B1 | COLORIMETRIC SENSOR FOR PH MEASUREMENTS | UNIV DEGLI STUDI PADOVA (IT) | 2024-04-03 | — | — | EP | claimed |
| EP-3961216-B1 | DIHYDROMYRICETIN FOR USE AS IMAGING AGENT | UNIV UNITED ARAB EMIRATES (AE) | 2024-02-14 | — | — | EP | claimed |
| EP-3360847-B1 | METAL OXIDE PARTICLES AND METHOD FOR PRODUCING SAME | M TECHNIQUE CO LTD (JP) | 2023-09-13 | — | — | EP | claimed |
| EP-4019645-B1 | METHODS AND KITS FOR DETECTING SPERM DNA FRAGMENTATION | BONRAYBIO CO LTD (TW) | 2023-08-23 | — | — | EP | claimed |
| WO-2023104380-A1 | SYNERGISTIC TRANSPORT OF LIPOPHILIC AND HYDROPHILIC ACTIVE SUBSTANCES IN NANOPARTICLES | Karlsruher Institut für Technologie (DE) | 2023-06-15 | — | — | WO | claimed |
| EP-3194937-B1 | METHOD FOR CONTROLLING DEPTH OF IMAGING IN TISSUES USING FLUORESCENCE MICROSCOPY UNDER ULTRAVIOLET EXCITATION FOLLOWING STAINING WITH FLUORESCING AGENTS | L LIVERMORE NAT SECURITY LLC (US) | 2023-06-07 | — | — | EP | claimed |
| EP-4190312-A1 | SYNERGISTIC TRANSPORT OF LIPOPHILIC AND HYDROPHILIC ACTIVE AGENTS INTO NANOPARTICLES | Karlsruher Institut für Technologie (DE) | 2023-06-07 | — | — | EP | claimed |
| EP-3099336-B1 | LIQUID COMPOSITION IN THE FORM OF EMULSION OR MICROEMULSION FOR RECTAL ADMINISTRATION CONTAINING AT LEAST ONE DYE, AND ITS USE IN A DIAGNOSTIC ENDOSCOPIC PROCEDURE OF SIGMOID COLON AND/OR RECTUM | COSMO TECHNOLOGIES LTD (IE) | 2023-04-26 | — | — | EP | claimed |
| EP-3850040-B1 | A STABILIZED CHLORINATED POLYVINYLCHLORIDE AND AN ARTICLE MADE THEREFROM | REAGENS SPA (IT) | 2023-04-19 | — | — | EP | claimed |
| EP-3573748-B1 | COLOURED ORGANIC/INORGANIC HYBRID MATERIALS AND METHOD FOR PREPARING SAME | CENTRE NAT RECH SCIENT (FR) | 2023-04-19 | — | — | EP | claimed |
| EP-3987059-B1 | A METHOD OF MEASURING THE PH OF A SAMPLE | DIAGONAL BIO AB (SE) | 2022-07-06 | — | — | EP | claimed |
| EP-3479846-B1 | HYDROGEL-BASED NANOEMULSION FOR SELECTIVELY LABELING CANCER LESION, AND PREPARATION METHOD THEREFOR | SEOUL NAT UNIV R&DB FOUNDATION (KR) | 2022-05-04 | — | — | EP | claimed |
| EP-4735111-A1 | SINGLE-DOMAIN ANTIBODY FOR INHIBITION OF NEUTROPHIL ELASTASE ACTIVITY | Université de Liège (BE) | 2026-05-06 | — | — | EP | disclosed |
| US-20260110682-A1 | COMPOSITIONS AND METHODS TARGETING SWIP-10 AND MBLAC1 FOR THE THERAPEUTIC MODULATION OF COPPER DYSHOMEOSTASIS | FLORIDA ATLANTIC UNIV BOARD OF TRUSTEES (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260061771-A1 | MULTI-CORE WRITING IMPLEMENT | PILOT CORPORATION KK (JP) | 2026-03-05 | — | — | US | disclosed |
| US-12552745-B2 | Compound for optical materials, curable composition, cured body, and optical article | TOKUYAMA CORPORATION (JP) | 2026-02-17 | — | — | US | disclosed |
| US-12535491-B2 | Vaccine comprising protein-targeted (PT) extracellular DNA isolated from bacterial matrix | Tets, Viktor Veniaminovich (US) | 2026-01-27 | — | — | US | disclosed |
| EP-4680668-A1 | PHOSPHORIC ACID ESTER COMPOSITIONS FOR FLAME-RETARDANT SOFT PVC WITH HIGH THERMOSTABILITY | LANXESS Deutschland GmbH (DE) | 2026-01-21 | — | — | EP | disclosed |
| US-20250355282-A1 | LAYERED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES | TOKUYAMA CORPORATION (JP) | 2025-11-20 | — | — | US | disclosed |
| EP-3690040-B1 | PROTEIN PRODUCTION METHOD AND DISACCHARIDE PRODUCTION METHOD | AJINOMOTO KK (JP) | 2025-10-29 | — | — | EP | disclosed |
| EP-4639076-A1 | METHOD AND DEVICE FOR DETERMINING THE LAYER THICKNESS OF HISTOLOGICAL SECTIONAL SPECIMENS AND DETERMINING THE CONCENTRATION OF BIOLOGICAL SUBSTANCES IN HISTOLOGICAL SPECIMENS | Technische Universität Dresden (DE) | 2025-10-29 | — | — | EP | disclosed |
| US-20250306019-A1 | Device for Detecting Misfolded Proteins and Methods of Use Thereof | COOPERSURGICAL, INC. | 2025-10-02 | — | — | US | disclosed |
| US-20250269070-A1 | Fluorescent Marker | UCL BUSINESS PLC (GB) | 2025-08-28 | — | — | US | disclosed |
| US-20250257162-A1 | CURABLE COMPOSITION, CURED BODY, LAMINATE, OPTICAL ARTICLE, LENS, AND EYEGLASSES | TOKUYAMA CORPORATION (JP) | 2025-08-14 | — | — | US | disclosed |
| EP-4582265-A1 | MULTI-CORE WRITING IMPLEMENT | Kabushiki Kaisha Pilot Corporation (also trading as Pilot Corporation) (JP) | 2025-07-09 | — | — | EP | disclosed |
| EP-4578919-A1 | AQUEOUS INK COMPOSITION FOR WRITING INSTRUMENTS, AND WRITING INSTRUMENT HOUSING SAME | Kabushiki Kaisha Pilot Corporation (also trading as Pilot Corporation) (JP) | 2025-07-02 | — | — | EP | disclosed |
| EP-4560367-A1 | LAYERED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES | TOKUYAMA CORPORATION (JP) | 2025-05-28 | — | — | EP | disclosed |
| EP-4549523-A1 | INK COMPOSITION FOR WRITING UTENSILS AND WRITING UTENSIL ACCOMMODATING SAME | Kabushiki Kaisha Pilot Corporation (also trading as Pilot Corporation) (JP) | 2025-05-07 | — | — | EP | disclosed |
| US-12292406-B2 | Device for detecting analytes in a sample, and methods of use thereof | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2025-05-06 | — | — | US | disclosed |
| US-12287450-B2 | Functional laminate and functional lens comprising the functional laminate | TOKUYAMA CORPORATION (JP) | 2025-04-29 | — | — | US | disclosed |
| US-12286411-B2 | Indane derivatives for use in the treatment of bacterial infection | ANTABIO SAS (FR) | 2025-04-29 | — | — | US | disclosed |
| CN-119757298-A | EHNV virus detection method and system based on dynamic fluorescence intensity monitoring | 深圳海关动植物检验检疫技术中心 | 2025-04-04 | — | — | CN | disclosed |
| US-20250083971-A1 | CERIUM (III) CARBONATE FORMULATIONS | UNIV CALIFORNIA (US) | 2025-03-13 | — | — | US | disclosed |
| US-12247985-B2 | Methods of detecting transthyretin | NOVO NORDISK A/S (DK) | 2025-03-11 | — | — | US | disclosed |
| US-12247013-B2 | Indane derivatives for use in the treatment of bacterial infection | ANTABIO SAS (FR) | 2025-03-11 | — | — | US | disclosed |
| EP-4516823-A1 | CURABLE COMPOSITION, CURED BODY, LAMINATE, OPTICAL ARTICLE, LENS, AND SPECTACLES | TOKUYAMA CORPORATION (JP) | 2025-03-05 | — | — | EP | disclosed |
| WO-2025038339-A1 | DEEP LEARNING MODEL TO DETERMINE A FIXATION STATUS OF A MORPHOLOGICALLY STAINED BIOLOGICAL SPECIMEN | VENTANA MEDICAL SYSTEMS, INC. (US) | 2025-02-20 | — | — | WO | disclosed |
| CN-119416213-A | Multi-classification dynamic detection method and system for Android malicious software | 内蒙古农业大学 | 2025-02-11 | — | — | CN | disclosed |
| EP-4492044-A1 | SENSOR ELEMENT FOR OPTOCHEMICAL SENSORS | PyroScience GmbH (DE) | 2025-01-15 | — | — | EP | disclosed |
| US-20250002541-A1 | ENGINEERED CENTRAL NERVOUS SYSTEM COMPOSITIONS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2025-01-02 | — | — | US | disclosed |
| WO-2025003495-A1 | SINGLE-DOMAIN ANTIBODY FOR INHIBITION OF NEUTROPHIL ELASTASE ACTIVITY | Université de Liège (BE) | 2025-01-02 | — | — | WO | disclosed |
| EP-4483951-A1 | SINGLE-DOMAIN ANTIBODY FOR INHIBITION OF NEUTROPHIL ELASTASE ACTIVITY | Université de Liège (BE) | 2025-01-01 | — | — | EP | disclosed |
| US-12180084-B2 | Cerium (III) carbonate formulations | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-12-31 | — | — | US | disclosed |
| US-20240424143-A1 | ENGINEERED MUSCLE AND CENTRAL NERVOUS SYSTEM COMPOSITIONS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2024-12-26 | — | — | US | disclosed |
| WO-2024254696-A1 | PLANT-BASED SCAFFOLDS AND TUNABLE HYDROGELS FOR BIOPRINTING AND METHODS THEREOF | UNIVERSITY OF OTTAWA (CA) | 2024-12-19 | — | — | WO | disclosed |
| US-20240409956-A1 | ENGINEERED CARDIAC MUSCLE COMPOSITIONS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2024-12-12 | — | — | US | disclosed |
| EP-4472997-A2 | TARGETING MOIETIES PROMOTING TRANSDUCTION OF CENTRAL NERVOUS SYSTEM CELLS AND TISSUES AND METHODS OF USE | The Broad Institute, Inc. (US) | 2024-12-11 | — | — | EP | disclosed |
| US-20240401149-A1 | TREATMENT OF CANCER BY RISK STRATIFICATION OF PATIENTS BASED ON COMORBIDITIES | REDDY BALAJI NARAYANA (US) | 2024-12-05 | — | — | US | disclosed |
| US-20240392028-A1 | METHOD OF TREATING MULTIPLE MYELOMA | CAELUM BIOSCIENCES INC (US) | 2024-11-28 | — | — | US | disclosed |
| US-20240384299-A1 | TARGETING MOIETIES PROMOTING TRANSDUCTION OF CENTRAL NERVOUS SYSTEM CELLS AND TISSUES AND METHODS OF USE | THE BROAD INSTITUTE, INC. | 2024-11-21 | — | — | US | disclosed |
| CN-118845912-A | Compositions and methods for treating plaque and tangles in humans and animals | 考格尼克拉瑞提公司 | 2024-10-29 | — | — | CN | disclosed |
| EP-4444275-A1 | SYNERGISTIC TRANSPORT OF LIPOPHILIC AND HYDROPHILIC ACTIVE SUBSTANCES IN NANOPARTICLES | Karlsruher Institut für Technologie (DE) | 2024-10-16 | — | — | EP | disclosed |
| WO-2024188777-A1 | PHOSPHORIC ACID ESTER COMPOSITIONS FOR FLAME-RETARDANT SOFT PVC WITH HIGH THERMOSTABILITY | LANXESS DEUTSCHLAND GMBH (DE) | 2024-09-19 | — | — | WO | disclosed |
| EP-4431561-A1 | PHOSPHORIC ACID ESTER COMPOSITIONS FOR FLAME RETARDANT SOFT PVC WITH HIGH THERMOSTABILITY | LANXESS Deutschland GmbH (DE) | 2024-09-18 | — | — | EP | disclosed |
| US-20240301042-A1 | SELECTIVE TARGETING OF OLIGOMERIC B-AMYLOID | NATIONAL INSTITUTES OF HEALTH | 2024-09-12 | — | — | US | disclosed |
| US-12065590-B2 | Adhesive composition, laminate and optical article comprising the laminate | TOKUYAMA CORPORATION (JP) | 2024-08-20 | — | — | US | disclosed |
| EP-4413025-A2 | ENGINEERED CARDIAC MUSCLE COMPOSITIONS | The Broad Institute, Inc. (US) | 2024-08-14 | — | — | EP | disclosed |
| US-20240254211-A1 | PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC AND AMYLOIDOGENIC DISEASE | PROTHENA BIOSCIENCES LTD (IE) | 2024-08-01 | — | — | US | disclosed |
| EP-4401839-A2 | METHOD OF TREATING MULTIPLE MYELOMA | Caelum Biosciences, Inc. (US) | 2024-07-24 | — | — | EP | disclosed |
| US-20240241291-A1 | FUNCTIONAL LAMINATE AND FUNCTIONAL LENS COMPRISING THE FUNCTIONAL LAMINATE | TOKUYAMA CORPORATION (JP) | 2024-07-18 | — | — | US | disclosed |
| EP-4399316-A1 | ENGINEERED MUSCLE AND CENTRAL NERVOUS SYSTEM COMPOSITIONS | The Broad Institute, Inc. (US) | 2024-07-17 | — | — | EP | disclosed |
| US-20240228947-A1 | BACTERIAL STRAINS HAVING FUNGICIDAL ACTIVITY, COMPOSITIONS COMPRISING SAME AND USE THEREOF | LAVIE BIO LTD. (IL) | 2024-07-11 | — | — | US | disclosed |
| WO-2024133511-A1 | METHOD AND DEVICE FOR DETERMINING THE LAYER THICKNESS OF HISTOLOGICAL SECTIONAL SPECIMENS AND DETERMINING THE CONCENTRATION OF BIOLOGICAL SUBSTANCES IN HISTOLOGICAL SPECIMENS | Technische Universität Dresden (DE) | 2024-06-27 | — | — | WO | disclosed |
| EP-4375382-A2 | BACTERIAL STRAINS HAVING FUNGICIDAL ACTIVITY, COMPOSITIONS COMPRISING SAME AND USE THEREOF | Lavie Bio Ltd. (IL) | 2024-05-29 | — | — | EP | disclosed |
| US-11988808-B2 | Functional laminate and functional lens comprising the functional laminate | TOKUYAMA CORPORATION (JP) | 2024-05-21 | — | — | US | disclosed |
| EP-3892228-B1 | MEDICAL INSTRUMENT OR PART OF A MEDICAL INSTRUMENT | AESCULAP AG (DE) | 2024-05-08 | — | — | EP | disclosed |
| US-20240141025-A1 | ANTI-TRANSTHYRETIN ANTIBODIES | NOVO NORDISK AS (DK) | 2024-05-02 | — | — | US | disclosed |
| EP-4349926-A1 | INK COMPOSITION FOR WRITING INSTRUMENT, AND WRITING INSTRUMENT ACCOMMODATING INK COMPOSITION FOR WRITING INSTRUMENT | Kabushiki Kaisha Pilot Corporation (also trading as Pilot Corporation) (JP) | 2024-04-10 | — | — | EP | disclosed |
| WO-2023039476-A9 | ENGINEERED MUSCLE AND CENTRAL NERVOUS SYSTEM COMPOSITIONS | THE BROAD INSTITUTE, INC. (US) | 2024-04-04 | — | — | WO | disclosed |
| WO-2024072744-A1 | METHODS AND SYSTEMS FOR ANNOTATING GENOMIC DATA | Martingale Labs, Inc. (US) | 2024-04-04 | — | — | WO | disclosed |
| WO-2024064357-A1 | COMPOSITIONS AND METHODS TARGETING SWIP-10 AND MBLAC1 FOR THE THERAPEUTIC MODULATION OF COPPER DYSHOMEOSTASIS | FLORIDA ATLANTIC UNIVERSITY BOARD OF TRUSTEES (US) | 2024-03-28 | — | — | WO | disclosed |
| EP-3779531-B1 | PHOTOCHROMIC OPTICAL ARTICLE AND METHOD FOR MANUFACTURING SAME | TOKUYAMA CORP (JP) | 2024-03-20 | — | — | EP | disclosed |
| EP-4334480-A1 | BACTERIAL STRAINS HAVING FUNGICIDAL ACTIVITY, COMPOSITIONS COMPRISING SAME AND USE THEREOF | Lavie Bio Ltd. (IL) | 2024-03-13 | — | — | EP | disclosed |
| US-11912759-B2 | Anti-transthyretin antibodies | NOVO NORDISK A/S (DK) | 2024-02-27 | — | — | US | disclosed |
| US-11883413-B2 | Inhibition of thymine DNA glycosylase in the treatment of cancer | INSTITUT CURIE (FR) | 2024-01-30 | — | — | US | disclosed |
| WO-2024018902-A1 | LAYERED BODY, OPTICAL ARTICLE, LENS, AND SPECTACLES | 株式会社トクヤマ | 2024-01-25 | — | — | WO | disclosed |
| US-20240016941-A1 | COMBINATION THERAPY | ANTABIO SAS (FR) | 2024-01-18 | — | — | US | disclosed |
| US-20240011099-A1 | STAINED BIOLOGICAL SPECIMENS INCLUDING ONE OR MORE BIOMARKERS LABELED WITH ONE OR MORE DETECTABLE MOIETIES | VENTANA MED SYST INC (US) | 2024-01-11 | — | — | US | disclosed |
| US-20230407355-A1 | METHOD FOR PREPARING XYLOGLUCAN-OLIGOSACCHARIDES | Technische Universität München (DE) | 2023-12-21 | — | — | US | disclosed |
| US-20230399650-A1 | PLASMID STABILISATION | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2023-12-14 | — | — | US | disclosed |
| EP-4281779-A1 | STAINED BIOLOGICAL SPECIMENS INCLUDING ONE OR MORE BIOMARKERS LABELED WITH ONE OR MORE DETECTABLE MOIETIES | Ventana Medical Systems, Inc. (US) | 2023-11-29 | — | — | EP | disclosed |
| US-20230364228-A1 | METHOD OF TREATING AMYLOIDOSIS | CAELUM BIOSCIENCES INC (US) | 2023-11-16 | — | — | US | disclosed |
| EP-2978805-B1 | STABILIZER COMPOSITIONS COMPRISING SALTS OF DICARBOXYLIC ACIDS AND POLYOLS | BAERLOCHER GMBH (DE) | 2023-11-15 | — | — | EP | disclosed |
| WO-2023210448-A1 | CURABLE COMPOSITION, CURED BODY, LAMINATE, OPTICAL ARTICLE, LENS, AND SPECTACLES | 株式会社トクヤマ | 2023-11-02 | — | — | WO | disclosed |
| WO-2023210447-A1 | METHOD FOR MANUFACTURING OPTICAL LAYERED SHEET AND METHOD FOR MANUFACTURING OPTICAL ARTICLE | 株式会社トクヤマ | 2023-11-02 | — | — | WO | disclosed |
| US-11788897-B2 | Time and/or temperature sensitive devices and methods of use thereof | FRESHPOINT QUALITY ASSURANCE LTD. (IL) | 2023-10-17 | — | — | US | disclosed |
| US-20230286912-A1 | COMPOUND FOR OPTICAL MATERIALS, CURABLE COMPOSITION, CURED BODY, AND OPTICAL ARTICLE | TOKUYAMA CORPORATION (JP) | 2023-09-14 | — | — | US | disclosed |
| CN-116710131-A | Use of epiregulin and amphiregulin to predict response to epidermal growth factor receptor directed therapies | 文塔纳医疗系统公司 | 2023-09-05 | — | — | CN | disclosed |
| US-20230272252-A1 | ADHESIVE COMPOSITION, LAMINATE AND OPTICAL ARTICLE COMPRISING THE LAMINATE | TOKUYAMA CORPORATION (JP) | 2023-08-31 | — | — | US | disclosed |
| WO-2023150632-A2 | TARGETING MOIETIES PROMOTING TRANSDUCTION OF CENTRAL NERVOUS SYSTEM CELLS AND TISSUES AND METHODS OF USE | THE BROAD INSTITUTE, INC. (US) | 2023-08-10 | — | — | WO | disclosed |
| EP-4217393-A1 | PREDICTION OF RESPONSE TO EPIDERMAL GROWTH FACTOR RECEPTOR-DIRECTED THERAPIES USING EPIREGULIN AND AMPHIREGULIN | Ventana Medical Systems, Inc. (US) | 2023-08-02 | — | — | EP | disclosed |
| EP-4210753-A1 | METHOD OF TREATING AMYLOIDOSIS | Caelum Biosciences, Inc. (US) | 2023-07-19 | — | — | EP | disclosed |
| EP-3601224-B1 | CHEMICAL COMPOUNDS AS ANTIBIOTICS | ANTABIO SAS (FR) | 2023-07-05 | — | — | EP | disclosed |
| CN-113024870-B | Medical glove and preparation method thereof | 华熙生物科技股份有限公司 | 2023-07-04 | — | — | CN | disclosed |
| US-20230193316-A1 | ENGINEERED CENTRAL NERVOUS SYSTEM COMPOSITIONS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2023-06-22 | — | — | US | disclosed |
| EP-4196591-A1 | PLASMID STABILISATION | Oxford University Innovation Limited (GB) | 2023-06-21 | — | — | EP | disclosed |
| WO-2023104380-A1 | SYNERGISTIC TRANSPORT OF LIPOPHILIC AND HYDROPHILIC ACTIVE SUBSTANCES IN NANOPARTICLES | Karlsruher Institut für Technologie (DE) | 2023-06-15 | — | — | WO | disclosed |
| US-20230173054-A1 | TARGET SEQUENCE OF RNA VIRUS AND USE THEREOF | SHANGHAI PUBLIC HEALTH CLINICAL CENTER (CN) | 2023-06-08 | — | — | US | disclosed |
| EP-4190312-A1 | SYNERGISTIC TRANSPORT OF LIPOPHILIC AND HYDROPHILIC ACTIVE AGENTS INTO NANOPARTICLES | Karlsruher Institut für Technologie (DE) | 2023-06-07 | — | — | EP | disclosed |
| EP-4180816-A2 | IMMUNOLOGICAL SOLID PHASE ASSAY WITH SPATIALLY RESOLVED SIGNAL (SFIDA) FOR QUANTIFICATION OF AT LEAST 2 PROTEIN AGGREGATES | Forschungszentrum Jülich GmbH (DE) | 2023-05-17 | — | — | EP | disclosed |
| EP-4180815-A2 | IMMUNOLOGICAL SOLID PHASE ASSAY WITH SPATIALLY RESOLVED SIGNAL (SFIDA) FOR QUANTIFICATION OF AT LEAST 2 PROTEIN AGGREGATES | Forschungszentrum Jülich GmbH (DE) | 2023-05-17 | — | — | EP | disclosed |
| US-11629185-B2 | Anti-transthyretin antibodies | NOVO NORDISK A/S (DK) | 2023-04-18 | — | — | US | disclosed |
| WO-2023060142-A2 | ENGINEERED CARDIAC MUSCLE COMPOSITIONS | THE BROAD INSTITUTE, INC. (US) | 2023-04-13 | — | — | WO | disclosed |
| EP-4163270-A1 | COMPOUND FOR OPTICAL MATERIAL, CURABLE COMPOSITION, CURED BODY, AND OPTICAL ARTICLE | Tokuyama Corporation (JP) | 2023-04-12 | — | — | EP | disclosed |
| US-11618913-B2 | Method for preparing xyloglucan-oligosaccharides | Technische Universität München (DE) | 2023-04-04 | — | — | US | disclosed |
| WO-2023043658-A2 | METHOD OF TREATING MULTIPLE MYELOMA | CAELUM BIOSCIENCES (US) | 2023-03-23 | — | — | WO | disclosed |
| WO-2023039476-A1 | ENGINEERED MUSCLE AND CENTRAL NERVOUS SYSTEM COMPOSITIONS | THE BROAD INSTITUTE, INC. (US) | 2023-03-16 | — | — | WO | disclosed |
| WO-2023039480-A2 | ENGINEERED CENTRAL NERVOUS SYSTEM COMPOSITIONS | THE BROAD INSTITUTE, INC. (US) | 2023-03-16 | — | — | WO | disclosed |
| EP-4143305-A2 | ENGINEERED CENTRAL NERVOUS SYSTEM COMPOSITIONS | The Broad Institute, Inc. (US) | 2023-03-08 | — | — | EP | disclosed |
| EP-4134379-A1 | ANTI-TRANSTHYRETIN ANTIBODIES | Prothena Biosciences Limited (IE) | 2023-02-15 | — | — | EP | disclosed |
| EP-4125883-A1 | COMBINATION THERAPY | Antabio SAS (FR) | 2023-02-08 | — | — | EP | disclosed |
| CN-115628961-A | Microsporidium fluorescent staining labeling method and application | 山东大学 | 2023-01-20 | — | — | CN | disclosed |
| WO-2022234569-A1 | BACTERIAL STRAINS HAVING FUNGICIDAL ACTIVITY, COMPOSITIONS COMPRISING SAME AND USE THEREOF | LAVIE BIO LTD. (IL) | 2022-11-10 | — | — | WO | disclosed |
| EP-3868846-B1 | DECORATIVE AND PROTECTIVE COATING COMPOSITION FOR METAL, GLASS AND PLASTIC SUBSTRATES | EPG F (FR) | 2022-11-02 | — | — | EP | disclosed |
| EP-3014279-B1 | METHOD FOR DETERMINING PROTEIN AGGREGATES USING SURFACE-FIDA | FORSCHUNGSZENTRUM JUELICH GMBH (DE) | 2022-10-12 | — | — | EP | disclosed |
| EP-3250592-B1 | ANTI-TRANSTHYRETIN ANTIBODIES | PROTHENA BIOSCIENCES LTD (IE) | 2022-10-05 | — | — | EP | disclosed |
| WO-2022204293-A1 | SELECTIVE TARGETING OF OLIGOMERIC Β‑AMYLOID | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2022-09-29 | — | — | WO | disclosed |
| EP-1578253-B2 | PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC DISEASE | PROTHENA BIOSCIENCES LTD (IE) | 2022-09-28 | — | — | EP | disclosed |
| US-20220295799-A1 | BACTERIAL STRAINS HAVING FUNGICIDAL ACTIVITY, COMPOSITIONS COMPRISING SAME AND USE THEREOF | LAVIE BIO LTD. (IL) | 2022-09-22 | — | — | US | disclosed |
| US-20220283116-A1 | DEVICE FOR DETECTING ANALYTES IN A SAMPLE, AND METHODS OF USE THEREOF | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2022-09-08 | — | — | US | disclosed |
| CN-110187119-B | Methods and compositions for the detection and treatment of preeclampsia | 耶鲁大学 | 2022-07-29 | — | — | CN | disclosed |
| WO-2022156920-A1 | STAINED BIOLOGICAL SPECIMENS INCLUDING ONE OR MORE BIOMARKERS LABELED WITH ONE OR MORE DETECTABLE MOIETIES | VENTANA MEDICAL SYSTEMS, INC. (US) | 2022-07-28 | — | — | WO | disclosed |
| EP-4028064-A1 | ENGINEERED ADENO-ASSOCIATED VIRUS CAPSIDS | The Broad Institute, Inc. (US) | 2022-07-20 | — | — | EP | disclosed |
| US-11384379-B2 | Method for producing a protein and disaccharide using a Talaromyces cellulolyticus | AJINOMOTO CO., INC. (JP) | 2022-07-12 | — | — | US | disclosed |
| US-20220212946-A1 | CERIUM (III) CARBONATE FORMULATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2022-07-07 | — | — | US | disclosed |
| CN-110187120-B | Methods and compositions for the detection and treatment of preeclampsia | 耶鲁大学 | 2022-07-01 | — | — | CN | disclosed |
| CN-110187121-B | Methods and compositions for the detection and treatment of preeclampsia | 耶鲁大学 | 2022-07-01 | — | — | CN | disclosed |
| EP-3250593-B1 | ANTI-TRANSTHYRETIN ANTIBODIES | PROTHENA BIOSCIENCES LTD (IE) | 2022-06-22 | — | — | EP | disclosed |
| EP-3438674-B1 | METHOD AND DEVICE FOR CLEANING PIPPETING TIPS | EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG (DE) | 2022-06-22 | — | — | EP | disclosed |
| EP-4013898-A1 | BACTERIAL STRAINS HAVING FUNGICIDAL ACTIVITY, COMPOSITIONS COMPRISING SAME AND USE THEREOF | Lavie Bio Ltd. (IL) | 2022-06-22 | — | — | EP | disclosed |
| EP-4007911-A1 | DEVICE FOR DETECTING ANALYTES IN A SAMPLE, AND METHODS OF USE THEREOF | King Abdullah University Of Science And Technology (SA) | 2022-06-08 | — | — | EP | disclosed |
| CN-106461644-B | Methods and compositions for detecting misfolded proteins | 耶鲁大学 | 2022-05-13 | — | — | CN | disclosed |
| WO-2022098847-A1 | TOLCAPONE ANALOGS AND METHODS OF USE | CORINO THERAPEUTICS, INC. (US) | 2022-05-12 | — | — | WO | disclosed |
| EP-3994227-A1 | COMPRESSIBLE UV-ACTIVATABLE OR THERMALLY ACTIVATABLE (SEMI-) STRUCTURAL ADHESIVE FILM THAT CHANGES COLOR AFTER ACTIVATION AND AFTER CURING | Lohmann GmbH & Co. KG (DE) | 2022-05-11 | — | — | EP | disclosed |
| CN-114445406-A | Enteroscopy image analysis method and device and medical image processing equipment | 武汉大学 | 2022-05-06 | — | — | CN | disclosed |
| US-20220112169-A1 | INDANE DERIVATIVES FOR USE IN THE TREATMENT OF BACTERIAL INFECTION | ANTABIO SAS (FR) | 2022-04-14 | — | — | US | disclosed |
| EP-3981442-A1 | MOBILE DEVICE OPERABLE BY MEANS OF A TEMPERATURE DIFFERENCE FOR CLEANING AND DISINFECTING ROOM AIR | Münch, Elke (DE) | 2022-04-13 | — | — | EP | disclosed |
| EP-3978038-A1 | MOBILE DEVICE OPERABLE BY MEANS OF A TEMPERATURE DIFFERENCE FOR CLEANING AND DISINFECTING ROOM AIR AND TEST DEVICE FOR SAME | Münch, Elke (DE) | 2022-04-06 | — | — | EP | disclosed |
| CN-107851551-B | Substrate processing method and semiconductor device | JSR株式会社 | 2022-04-05 | — | — | CN | disclosed |
| US-20220101960-A1 | METHOD AND APPARATUS FOR ANALYSIS OF HISTOPATHOLOGY DATASETS | SIEMENS HEALTHCARE GMBH (DE) | 2022-03-31 | — | — | US | disclosed |
| WO-2022066512-A1 | PREDICTION OF RESPONSE TO EPIDERMAL GROWTH FACTOR RECEPTOR-DIRECTED THERAPIES USING EPIREGULIN AND AMPHIREGULIN | VENTANA MEDICAL SYSTEMS, INC. (US) | 2022-03-31 | — | — | WO | disclosed |
| US-11286491-B2 | Biosynthetic amyloid-based materials displaying functional protein sequences | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2022-03-29 | — | — | US | disclosed |
| US-20220092774-A1 | METHOD AND APPARATUS FOR ANALYSIS OF HISTOPATHOLOGY IMAGE DATA | SIEMENS HEALTHCARE GMBH (DE) | 2022-03-24 | — | — | US | disclosed |
| WO-2022056484-A1 | METHOD OF TREATING AMYLOIDOSIS | CAELUM BIOSCIENCES (US) | 2022-03-17 | — | — | WO | disclosed |
| US-11267878-B2 | Anti-transthyretin antibodies | NEOTOPE NEUROSCIENCE LIMITED (IE) | 2022-03-08 | — | — | US | disclosed |
| US-11267877-B2 | Anti-transthyretin antibodies | NEOTOPE NEUROSCIENCE LIMITED (IE) | 2022-03-08 | — | — | US | disclosed |
| EP-3958984-A1 | CERIUM (III) CARBONATE FORMULATIONS | The Regents of the University of California (US) | 2022-03-02 | — | — | EP | disclosed |
| US-11259767-B2 | Systems and methods for enhanced diagnosis of transthyretin cardiac amyloidosis | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2022-03-01 | — | — | US | disclosed |
| US-20220054500-A1 | Inhibition of Thymine DNA Glycosylase in the Treatment of Cancer | INSTITUT CURIE (FR) | 2022-02-24 | — | — | US | disclosed |
| US-20220054500-A1 | Inhibition of Thymine DNA Glycosylase in the Treatment of Cancer | INSTITUT CURIE (FR) | 2022-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220112169-A1 | INDANE DERIVATIVES FOR USE IN THE TREATMENT OF BACTERIAL INFECTION | ARG1, ELANE, INSR | THRB 1299/4885APP 2756/4885GLB1 2153/4885 |
| US-12552745-B2 | Compound for optical materials, curable composition, cured body, and optical article | C5, SCO2, ZYX | THRB 2158/4885APP 3099/4885GLB1 975/4885 |
| US-20230286912-A1 | COMPOUND FOR OPTICAL MATERIALS, CURABLE COMPOSITION, CURED BODY, AND OPTICAL ARTICLE | C5, CORO1A, CCNO | THRB 2368/4885APP 1412/4885GLB1 1668/4885 |
| US-12286411-B2 | Indane derivatives for use in the treatment of bacterial infection | ELANE, ARG1, INSRR | THRB 1364/4885APP 2628/4885GLB1 1814/4885 |
| US-20240016941-A1 | COMBINATION THERAPY | CFTR, ABCB11, SLC26A4 | THRB 812/4885APP 4351/4885GLB1 1734/4885 |
| US-12535491-B2 | Vaccine comprising protein-targeted (PT) extracellular DNA isolated from bacterial matrix | PRNP, WIZ, PSEN1 | THRB 761/4885APP 21/4885GLB1 4498/4885 |
| US-20220054500-A1 | Inhibition of Thymine DNA Glycosylase in the Treatment of Cancer | UNG, MPG, TYMP | THRB 1508/4885APP 1323/4885GLB1 124/4885 |
| US-20260061771-A1 | MULTI-CORE WRITING IMPLEMENT | TYR, PIK3C3, PRKDC | THRB 2113/4885APP 4207/4885GLB1 2386/4885 |
| US-11883413-B2 | Inhibition of thymine DNA glycosylase in the treatment of cancer | UNG, MPG, TYMP | THRB 1508/4885APP 1323/4885GLB1 124/4885 |
| US-12247013-B2 | Indane derivatives for use in the treatment of bacterial infection | ELANE, ARG1, INSRR | THRB 1364/4885APP 2628/4885GLB1 1814/4885 |
| US-20240254211-A1 | PREVENTION AND TREATMENT OF SYNUCLEINOPATHIC AND AMYLOIDOGENIC DISEASE | SNCA, PARK7, GAP43 | THRB 4306/4885APP 32/4885GLB1 100/4885 |
| US-20260110682-A1 | COMPOSITIONS AND METHODS TARGETING SWIP-10 AND MBLAC1 FOR THE THERAPEUTIC MODULATION OF COPPER DYSHOMEOSTASIS | WDR1, WDR3, WDR26 | THRB 2868/4885APP 2037/4885GLB1 1857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.